Comparison of DOTA and NODAGA as chelates for 68Ga-labelled CDP1 as novel infection PET imaging agents

被引:5
|
作者
Mdlophane, A. H. [1 ,2 ,3 ]
Ebenhan, T. [1 ,2 ,4 ]
Marjanovic-Painter, B. [3 ]
Govender, T. [5 ,6 ]
Sathekge, M. M. [1 ,2 ,4 ]
Zeevaart, J. R. [3 ,4 ,7 ]
机构
[1] Univ Pretoria, Nucl Med, Crn Malherbe & Steve Biko Rd, ZA-0001 Pretoria, South Africa
[2] Steve Biko Acad Hosp, Crn Malherbe & Steve Biko Rd, ZA-0001 Pretoria, South Africa
[3] South African Nucl Energy Corp Necsa, Radiochem, Pelindaba, Bldg P1600, ZA-0240 Brits, South Africa
[4] Pelindaba, Preclin Imaging Facil, Nucl Med Res Infrastruct NuMeRI, ZA-0240 Brits, South Africa
[5] Univ KwaZulu Natal, Sch Hlth Sci, Catalysis & Peptide Res Unit, ZA-4001 Durban, South Africa
[6] Univ KwaZulu Natal, Sch Chem & Phys, ZA-4001 Durban, South Africa
[7] North West Univ, Dept Sci & Technol Preclin Drug Dev Platform, 11 Hoffman St, ZA-2520 Potchefstroom, South Africa
关键词
CDP1; NODAGA; DOTA; Ga-68; Antimicrobial peptides; Infection imaging; PET; ANTIMICROBIAL PEPTIDES; UBIQUICIDIN; ANTIBACTERIAL; COMPLEXES; TRACER; GA-68; LL-37;
D O I
10.1007/s10967-019-06693-5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The cathelicidin-derived peptide (CDP1) is a human antimicrobial peptide that preferentially targets bacterial membranes in response to infection. CDP1 was functionalised with NODAGA and DOTA for complexation with gallium-68 to evaluate its potential as an infection imaging tracer. The synthesis of [Ga-68]Ga-NODAGA-CDP1 and [Ga-68]Ga-DOTA-CDP1 were optimised for pH, molarity, incubation time and temperature, and product purification. The integrity and protein binding were investigated employing [Ga-68]GaCl3 and [Ga-68]Ga-DOTA-TATE as internal references. [Ga-68]Ga-NODAGA-CDP1 displayed good labelling properties with higher product yield compared to [Ga-68]Ga-DOTA-CDP1. In contrast, [Ga-68]Ga-DOTA-CDP1 showed better stability and is the preferred candidate for an in vivo investigation.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 44 条
  • [41] Preclinical and first-in-human evaluation of [68Ga]Ga-DOTA-PEG2-Asp2-PDL1P PET imaging to assess tumor PD-L1 expression
    Chen, Yang
    Hu, Yinting
    Li, Ao
    Zhang, Guojin
    Guo, Danyi
    Yao, Xinchao
    Zeng, Baozhen
    Tang, Ganghua
    Jiang, Benyuan
    Jiang, Lei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [42] 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones
    Petteri Lankinen
    Tatu J. Mäkinen
    Tiina A. Pöyhönen
    Pauliina Virsu
    Satu Salomäki
    Antti J. Hakanen
    Sirpa Jalkanen
    Hannu T. Aro
    Anne Roivainen
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 352 - 364
  • [43] 68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones
    Lankinen, Petteri
    Maekinen, Tatu J.
    Poeyhoenen, Tiina A.
    Virsu, Pauliina
    Salomaeki, Satu
    Hakanen, Antti J.
    Jalkanen, Sirpa
    Aro, Hannu T.
    Roivainen, Anne
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) : 352 - 364
  • [44] Comparative study of [18F]AlF-PAI-PDL1p and [68Ga]Ga-PAI-PDL1p as novel PD-L1 targeting PET probes for tumor imaging
    Bai, Lu
    Sun, Penghui
    Huang, Shun
    Shi, Dazhi
    Cheng, Kui
    Cai, Zhikai
    Dong, Ye
    Tang, Ganghua
    BIOORGANIC CHEMISTRY, 2024, 151